Stem Cell Manufacturing Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Stem Cell Manufacturing Market?
The growing population of older adults is anticipated to boost the stem cell manufacturing market. The term “geriatric population” is used to describe individuals aged 65 or over. This age group is more susceptible to various diseases due to decreased immunity and aging. The stem cell manufacturing industry plays a crucial role in combating these age-related diseases, as the risk of chronic illnesses increases with age. To illustrate, the Population Reference Bureau, a non-profit organization based in Kenya, reported in January 2024 that by 2050, the American population aged 65 and older is projected to expand from 58 million in 2022 to 82 million, a surge of 47%. The proportion of this age group in relation to the total population is also anticipated to increase from 17% to 23% during this timeframe. Therefore, the increasing geriatric population is contributing to the expansion of the stem cell manufacturing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp
#What is the Growth Potential of the Stem Cell Manufacturing Market, and How Will It Perform by 2034?
Recently, there has been significant growth in the size of the stem cell manufacturing market. It is foreseen to expand from $17.5 billion in 2024 to $19.22 billion in 2025, displaying a compound annual growth rate (CAGR) of 9.8%. This progression during the historic period can be credited to advancements in biotechnology, efforts in research and development, clinical trials and therapeutic applications, the establishment of a regulatory framework, and investments into infrastructure.
There is anticipation for substantial growth in the stem cell manufacturing market size within the upcoming years. It’s expected to inflate to a size of $30.27 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. This projected growth within the forecast period can be linked to factors such as increased financial contributions and investments, the expansion of therapeutic applications, the advent of cellular therapies, an increase in clinical trials and approvals, and the adaptation of personalized and patient-specific treatments. Key trends to expect in the future include a focus on 3D bioprinting, an increase in induced pluripotent stem cells (ipscs), the integration of automation and robotics, standardization and scalability, and progress in bioreactor technology.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9402
What Are the Key Market Innovations in theStem Cell Manufacturing Market Over the Coming Years?
Technological innovation is a crucial factor driving the stem cell production market. Many of the market’s participants are utilizing advanced technologies to remain competitive. For instance, Bluebird Bio Inc., a biotech firm based in the United States, received approval from the U.S. Food and Drug Administration (FDA) for ZYNTEGLO in August 2022. This represents a pioneering gene therapy that has received approval for treating beta-thalassemia in patients who require regular red blood cell transfusions. Its unique ex-vivo method involves integrating a modified beta-globin gene into the patient’s hematopoietic stem cells, allowing them to produce normal hemoglobin levels. The goal of this innovative treatment is to achieve independence from transfusions, greatly reducing the treatment burden for those suffering from beta-thalassemia. The approval of ZYNTEGLO is a significant breakthrough in gene therapy and it may provide a cure, improving the quality of life for those affected.
Who Are the Top Companies Driving Innovation and Growth in theStem Cell Manufacturing Market?
Major companies operating in the stem cell manufacturing market include Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report
Which Key Market Segments Comprise the Stem Cell Manufacturing Market and Drive Its Revenue Growth?
The stem cell manufacturing market covered in this report is segmented –
1) By Product: Consumables, Instruments, Stem Cell Lines
2) By Application: Research Applications, Clinical Application, Cell And Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users
Subsegments:
1) By Consumables: Media And Reagents, Cell Culture Vessels, Assay Kits
2) By Instruments: Bioreactors, Cell Counters, Flow Cytometers
3) By Stem Cell Lines: Embryonic Stem Cell Lines, Adult Stem Cell Lines, Induced Pluripotent Stem Cell Lines (iPSCs)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=9402&type=smp
Which Regions Are Emerging as Leaders in the Stem Cell Manufacturing Market?
North America was the largest region in the stem cell manufacturing market in 2024. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Stem Cell Manufacturing Maret 2025, By The Business Research Company:
Monoclonal Antibodies (MAs) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Neurology Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
